№ files_lp_4_process_3_083991
File format: docx Character count: 3462 File size: 97 KB
Information for patients switching from Atripla® to generic tenofovir, emtricitabine and efavirenz is a patient information leaflet explaining the changes in medication and its administration, and addressing possible side effects.
Year: 2018
Region / city: United Kingdom, Ireland
Subject: Medicine information
Document type: Patient information leaflet
Organization: HIV Pharmacy Association (HIVPA)
Author: HIV Pharmacy Association (HIVPA)
Target audience: Patients switching from Atripla to generic tenofovir, emtricitabine, and efavirenz
Effective period: From February 2018
Approval date: February 2018
Date of changes: Not mentioned
Contact: Telephone number: [Provided in document]
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Topics: Atripla efavirenz emtricitabine